| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 41,443 | 45,352 | 42,263 | 42,324 | | Cost of Revenue | 10,097 | 11,072 | 12,060 | 13,263 | | | Gross Profit |
-
| 34,280 | 30,203 | 29,061 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,528 | 14,588 | 14,701 | 13,793 | | Non Recurring |
-
| 102 | (102) |
-
| | Others | 10,177 | 7,477 | 10,882 | 6,698 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 12,113 | 4,722 | 8,570 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,641 | 12,113 | 4,722 | 8,570 | | Interest Expense | 2,236 | 2,563 | 2,688 | 3,218 | | Income Before Tax | 3,405 | 9,550 | 2,034 | 5,352 | | Income Tax Expense | 1,271 | 3,605 | 705 | 2,127 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,134 | 5,945 | 1,329 | 3,225 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,134 | 5,945 | 1,329 | 3,225 | | Preferred Stock And Other Adjustments |
-
| (1,035) | (1,033) | (243) | | | Net Income Applicable To Common Shares | $1,097 | $4,910 | $296 | $2,982 |
|
0.51% Nasdaq 
Income Statement
